BridgeMD
New treatment option for Preterm Birth
Official title Transition From Donor Milk: a Feasibility Study
ClinicalTrials.gov ID: NCT06514014
What this study is testing
- What it's testing
- Preterm and very low birth weight (VLBW, \< 1,500g) infants who receive donor human milk (DHM) often experience slow postnatal growth and no clinical data is available to guide the duration of DHM for preterm infants. The investigators hypothesize that transitioning from DHM to preterm infant formula after the first month of life is both safe and conveys improved weight and length gains and fat free mass accumulation.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 28 and older
You may be able to join if
- Greater than 1,250 grams
- At least 28 days of life
- Diet consisting of donor human milk with/without mother's own milk
You likely can't join if
- Birth weight below the 5th percentile
- History of necrotizing enterocolitis, spontaneous intestinal perforation, or other gastrointestinal disorder
- Congenital anomalies
- Care team discretion
The study team makes the final eligibility decision.
Where it's taking place
- Augusta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 28 days and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Augusta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.